Top compounds associated with response to PTGDR


Feature Type Standardized
Nominal ANOVA
mRNA ML320 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.098 0.0004
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA dexamethasone CTRPv2 pan-cancer AAC 0.11 0.001
mRNA decitabine CTRPv2 pan-cancer AAC 0.084 0.002
mRNA Nutlin-3 CTRPv2 pan-cancer AAC 0.1 0.002
mRNA CX-5461 GDSC1000 pan-cancer AAC 0.093 0.002
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.002
mRNA BRD-K88742110 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA STF-62247 GDSC1000 pan-cancer AAC 0.092 0.003
Download CSV